From April 1, 2024 to June 28, 2024, the company has repurchased 386,083 shares, representing 4.19% for KRW 1,624.45 million. With this, the company has completed the repurchase of 436,083 shares, representing 4.73% for KRW 1,819 million under the buyback announced on March 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,000 KRW | -0.37% |
|
-3.03% | -2.20% |
1st Jan change | Capi. | |
---|---|---|
-2.20% | 26.58M | |
+15.92% | 6.87B | |
+7.90% | 3.64B | |
+70.68% | 2.38B | |
+6.50% | 2.31B | |
+21.56% | 2.33B | |
+11.82% | 2.35B | |
+5.23% | 1.76B | |
+34.89% | 1.71B | |
-0.90% | 1.58B |
- Stock Market
- Equities
- A318160 Stock
- News Cell Bio Human Tech Co., Ltd
- Tranche Update on Cell Bio Human Tech Co., Ltd's Equity Buyback Plan announced on March 26, 2024.